Klaus Jung

发表

Adjusted Confidence Intervals for the Expression Change of Proteins Observed in 2-Dimensional Difference Gel Electrophoresis

Kai Stühler, Martin Eisenacher, Klaus Jung, 2009 .

Centrifugal Pump Lexicon - Updated 3. edition

Klaus Jung, Kurt Holzenberger, 1990 .

Additional file 2: of Comparative study on gene set and pathway topology-based enrichment methods

Klaus Jung, Frank Kramer, Annalen Bleckmann, 2015 .

Measuring reproducibility of virus metagenomics analyses using bootstrap samples from FASTQ-files

Klaus Jung, Ursula Siebert, Babak Saremi, 2020, Bioinform..

Avoiding pitfalls in applying prediction models, as illustrated by the example of prostate cancer diagnosis.

Klaus Jung, Henning Cammann, Carsten Stephan, 2011, Clinical chemistry.

Set-Based Test Procedures for the Functional Analysis of Protein Lists from Differential Analysis.

Klaus Jung, Jochen Kruppa, K. Jung, 2016, Methods in molecular biology.

Statistics in experimental design, preprocessing, and analysis of proteomics data.

Klaus Jung, K. Jung, 2011, Methods in molecular biology.

PSA and other tissue kallikreins for prostate cancer detection.

Klaus Jung, Carsten Stephan, C. Stephan, 2007, European journal of cancer.

An artificial neural network considerably improves the diagnostic power of percent free prostate‐specific antigen in prostate cancer diagnosis: Results of a 5‐year investigation

Dietmar Schnorr, Steffen Hauptmann, Klaus Jung, 2002, International journal of cancer.

Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression.

Kurt Miller, Klaus Jung, Carsten Stephan, 2011, The Journal of urology.

Comparison of eight computer programs for receiver-operating characteristic analysis.

Klaus Jung, Carsten Stephan, Tania Schink, 2003, Clinical chemistry.

Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.

Klaus Jung, Arndt Hartmann, Axel Semjonow, 2007, The Journal of urology.

A (-5, -7) proPSA based artificial neural network to detect prostate cancer.

Klaus Jung, Henning Cammann, Carsten Stephan, 2006, European urology.

Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies.

Klaus Jung, Henning Cammann, Carsten Stephan, 2002, Clinical chemistry.

Differential Expression of a Human Kallikrein 5 (KLK5) Splice Variant in Ovarian and Prostate Cancer

Klaus Jung, George M Yousef, Carsten Stephan, 2004, Tumor Biology.

Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?

Andreas Nitsche, Klaus Jung, Chuanliang Xu, 2005, Journal of Molecular Medicine.

MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy

Hans Lehrach, Klaus Jung, Christian Pilarsky, 2009, Journal of cellular and molecular medicine.

A bibliometric evaluation of publications in urological journals among European Union countries between 2000-2005.

Klaus Jung, K. Jung, Robert Peters, 2007, European urology.

Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model

Klaus Jung, S. Loening, K. Jung, 2005, The Prostate.

Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma

Klaus Jung, Ergin Kilic, K. Jung, 2016, PLoS ONE.

Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer

Klaus Jung, George M Yousef, Carsten Stephan, 2006, International journal of urology : official journal of the Japanese Urological Association.

New markers and multivariate models for prostate cancer detection.

Kurt Miller, Klaus Jung, Henning Cammann, 2009, Anticancer research.

A New Algorithm for Integrated Analysis of miRNA-mRNA Interactions Based on Individual Classification Reveals Insights into Bladder Cancer

Klaus Jung, Robert Preissner, Carsten Stephan, 2013, PloS one.

Analysis of subforms of free prostate-specific antigen in serum by two-dimensional gel electrophoresis: potential to improve diagnosis of prostate cancer.

Dietmar Schnorr, Klaus Jung, Carsten Stephan, 2004, Clinical chemistry.

Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p

Klaus Jung, Carsten Stephan, Ergin Kilic, 2016, PloS one.

Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update.

Dietmar Schnorr, Klaus Jung, Carsten Stephan, 2006, Clinical chemistry.

Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers

Klaus Jung, Carsten Stephan, C. Stephan, 2002, The Prostate.

Artificial neural networks and prostate cancer—tools for diagnosis and management

Kurt Miller, Klaus Jung, Henning Cammann, 2013, Nature Reviews Urology.

Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate‐specific antigen levels ≤ 10 ng/ml

Klaus Jung, Henning Cammann, Carsten Stephan, 2004, Cancer.

Metabolic profiling reveals key metabolic features of renal cell carcinoma

Joachim Selbig, Lothar Willmitzer, Kurt Miller, 2009, Journal of cellular and molecular medicine.

Evaluation of magnetic fluid hyperthermia in a standard rat model of prostate cancer.

Klaus Jung, S. Loening, K. Jung, 2004, Journal of endourology.